Riverdale, MD – According to filings with the U.S. Securities and Exchange Commission, Medcura is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Larry Tiffany played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Medcura

Medcura offers barriers that keep blood where it is supposed to be in the patient and keep bugs, dirt and other pathogens out. Our products rapidly stop bleeding independent of the body’s clotting cascade, and work on wounds of all shapes and sizes. Using safe and naturally abundant biomaterials, our FDA-cleared products treat bleeding from the battlefield to the backyard.

To learn more about Medcura, visit http://www.medcurainc.com/

Contact:
Larry Tiffany, Chief Executive Officer
240-684-8801
https://www.linkedin.com/in/larry-tiffany-39a7054a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved